Klinische Studien UKRO

SAKK 15/12

Early prophylactic cranial irradiation with hippocampal avoidance in patients with limited disease small-cell lung cancer. A multicenter phase II trial
Inselspital: O. Eliçin
Activated

IELSG 37

A randomized, open-label, multicenter, two-arm phase III comparative study assessing the role of mediastinal radiotherapy after Rituximab containing chemotherapy regiments to patients with newly diagnosed Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).
Inselspital: Dr. med. C. Ionescu
Activated
http://www.ielsg.org/

SAKK 63/12

Prospective cohort study with collection of clinical data and serum of patients with prostate disease
Inselspital: Prof. Dr. med. G. Thalmann
Activated

LungART (EORTC 22055-08053)

Phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement.
Inselspital: O. Elicin
Activated

METBO

Radiation metabolic signature of patients undergoing radiotherapy. A Pilot Study.
Inselspital: Dr. med. K. Lössl
Activated

Microbiota

Translational studies on the long-term effects of recovery of the composition of the intestinal microbiota following treatment of intestinal and pelvic tumours
Inselspital: Prof. Dr. med. A.J. Macpherson
Activated

PET-Plan

Optimierung der Strahlentherapieplanung von Patienten mit inoperablen lokal fortgeschrittenen nicht-kleinzelligen Bronchialkarzinome mittels F-18-FDG. Prospektive randomisierte multizentrische Therapieoptimierungsstudie.
Inselspital: O. Elicin
Activated

CHUV-CePO-20080214

Phase II study of concomitant intensity-modulated radiotherapy combined to capecitabine, mitomycin and panitumumab in patients with stage II -IIIB squamous-cell carcinoma of the anal canal
Inselspital: Dr. med. E. Herrmann
Activation in process

SAKK 01/10-EudractCt No 2011-005840-87

Carboplatin chemotherapy and involved node radiotherapy in Stage IIA/IIB Seminoma
Inselspital: Prof. Dr. med. D. Aebersold
Activated

STAMPEDE /EudraCT Nr.:2004-000193-31

Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy.
Activated

Multizenter-APBI-Phase-III-Studie

Multizenter-APBI-Phase-III-Studie Studienkontakt Bern:
Dr. med. Kristina Lössl, Email: kristina.loessl@no-spaminsel.ch

Establishing Novel MR - Criteria for the Assessment of Malignant Glioma Progression

SNF: 320030_140958
Inselspital PhD. J. Slotboom, Prof. Dr. med. R. Wiest, Prof. Dr. med. A. Raabe, PD Dr. med. A. Pica
Activated

DOSIS

Dose-intensified Image-guided Fractionated Stereotactic Body Radiation Therapy for Painful Spinal Metastases (DOSIS) versus Conventional Radiation Therapy: a Phase II Randomized Controlled Trial.
Inselspital: PD Dr. med. A. Jensen
Activation in process

PEINCA

Mixed Methods Study to test the efficacy of the adapted german pro-self plus pain control program, an intervention directed at outpatients with cancer and their family caregivers to reduce pain and related symptoms
Inselspital: Dr. Elisabeth Spichiger (PhD, RN)
Activation in process

SAKK 09/10
Dose intensified salvage radiotherapy in biochemically relapsed prostate cancer without macroscopic disease. A randomized phase III trial.
Inselspital: Dr. med. A. Dal Pra
Closed
http://www.sakk.ch/ 
http://www.clinicaltrials.gov/ct2/show/NCT01272050 
www.sakk0910rt.ch

EORTC 22042-26042

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study
Activated
Inselspital: Dr. med. E. Herrmann
Closed
http://www.eortc.be

IBCSG 38-10/BIG 3-07/TROG 07.01

Randomisierte Phase III Studie zu Bestrahlungsdosen und Fraktionierungsschemata 
bei duktalem Carcinoma in situ (DCIS) der Brust mit mittlerem und hohem Rückfall-Risiko.
Inselspital: Dr. med. K. Lössl
Closed

SENS

A structured early palliative care intervention for patients with advanced cancer - a randomized controlled trial with a nested qualitative study
Inselspital: PD Dr. med. K. Zaugg
Activated

Med. Onkologie

http://www.insel.ch

SAKK 16/08

Preoperative chemotherapy and radiotherapy concomitant to Cetuximab in non-small cell lung cancer (NSCLC) patients with IIIB disease. A multicenter phase II trial.
Inselspital: Prof. A. Ochsenbein
Activated
http://www.sakk.ch/

HD 16 / EudraCT Nr.: 2007-04474-24
für frühe Stadien Therapieoptimierungsstudie in der Primärtherapie des frühen Hodgkin Lymphom. Therapiestratifizierung mittels FDG-FET
Inselspital: Prof. Th. Pabst
Activated
Link Homepage: http://www.ghsg.org

HD 17 for intermediate stages

Treatment optimization trial in the first-line treatment of intermediate stage of Hodgkin lymphoma; treatment stratification by means of FDG-PET
Activated
Inselspital: Prof. Th. Pabst